QIAGEN launches enhanced GeneGlobe Design & Analysis Hub, combining curated knowledge, content-based assays and analyses for life science research
Hilden, Germany, and Germantown, Maryland, September 30, 2019 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its newly enhanced GeneGlobe Design & Analysis Hub, bringing next-level experiment planning, execution and follow-up to life science researchers. GeneGlobe integrates QIAGEN’s deep, manually curated knowledge base on over 10,000 biological entities with the... Read more